Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

01.06.2015 | editorial

PET/CT in management of oncologic patients

verfasst von: Prof. Dr. Siroos Mirzaei, MD, Prof. Dr. Abass Alavi, MD (Hon), PhD (Hon), DSc (Hon)

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Excerpt

This issue of the journal contains review articles concerning the role of positron emission tomography (PET) in the management of oncologic patients. …
Vorheriger Artikel Targeting oncogenic drivers in lung cancer: celebrating a decade of progress
Nächster Artikel New targets in breast cancer
Literatur
1.
Marino MA, Helbich TH, Blandino A, et al. The role of positron emission tomography in breast cancer: a short review. Memo 2015;2. Doi: 10.1007/s12254-015-0215-7.
2.
Vassilakopoulos TP, Prassopoulos V, Rondogianni P, et al. Role of 18FDG-PET/CT in staging and first-line treatment of Hodgkin and aggressive B-cell lymphomas. Memo 2015;2. Doi: 10.1007/s12254-015-0215-7.
3.
Roelcke U. Amino acid PET monitoring in gliomas. Memo 2015;2. Doi: 10.1007/s12254-015-0209-5.
4.
Tufman A, Müller-Lisse U, Reu S, et al. The relevance of positron emission tomography response in non-small cell lung cancer. Memo 2015;2. Doi: 10.1007/s12254-015-0213-9.
5.
Hickeson M, Yun M, Matthies A, et al. Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET. Eur J Nucl Med Mol Imaging. 2002;29:1639–47.
6.
Basu S, Zaidi H, Salavati A, et al. FDG PET/CT methodology for evaluation of treatment response in lymphoma: from “graded visual analysis” and “semiquantitative SUVmax” to global disease burden assessment. Eur J Nucl Med Mol Imaging. 2014;41:2158–60.PubMedCrossRef
7.
Cheng G, Torigian DA, Zhuang H, et al. When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET? Eur J Nucl Med Mol Imaging. 2013;40:779–87.PubMedCrossRef
8.
Kwee T, Basu S, Saboury B, et al. A new dimension of FDG-PET interpretation: assessment of tumor biology. Eur J Nucl Med Mol Imaging. 2011;38:1158–70.PubMedCrossRef
Metadaten
Titel
PET/CT in management of oncologic patients
verfasst von
Prof. Dr. Siroos Mirzaei, MD
Prof. Dr. Abass Alavi, MD (Hon), PhD (Hon), DSc (Hon)
Publikationsdatum
01.06.2015
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 2/2015
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-015-0212-x

Weitere Artikel der Ausgabe 2/2015

Amino acid PET monitoring in gliomas

  • short review

Potential impact of the hypomethylating agent 5-azacitidine on chronic lymphocytic leukemia with del(17)(p)/del(p53) and subsequent therapy-related acute myeloid leukemia without these aberrations: a case report

  • case report

Lung cancer in Bulgaria ‒ diagnosis, treatment, and factors affecting survival

  • original report

Esthesioneuroblastoma metastatic to the neck and lung: a case report and review of the literature

  • case report

Targeting oncogenic drivers in lung cancer: celebrating a decade of progress

  • editorial

New targets in gastric cancer

  • review